NSE Announcements on Sun Pharma
Posted by :
Poppee55Sun scrip price will certainly shoot up now. Expect to reach 1290/-...
NSE Announcements on Sun Pharma
Posted by :
MMB MessengerSun Pharmaceuticals Industries Ltd has informed the Exchange regarding a press release dated September 14, 2009, titled "Sun Pharmaceutical Announces Expiration of HSR Act Waiting Period for Taro Tender Offer". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
NSE Announcements on Sun Pharma
Posted by :
MMB MessengerSun Pharmaceuticals Industries Ltd has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on September 11, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
BSE Announcements on Sun Pharma
Posted by :
MMB MessengerSun Pharmaceutical Industries Ltd has informed BSE that the 17th Annual General Meeting (AGM) of the Company was held on September 11, 2009. ...
happy days are here again...............TARGET 1500+ in short period
Posted by :
cjvoraall bad days gone and happy days are return....TARGET for sun withing 3 months was 1500+,never sale any of your this shares but infect purchase in every deep......happy investment....
NSE Announcements on Sun Pharma
Posted by :
MMB MessengerSun Pharmaceuticals Industries Ltd has informed the Exchange regarding a press release dated August 28, 2009, titled "Sun Pharmaceutical Files HSR Application for Taro Tender Offer". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
BSE Announcements on Sun Pharma
Posted by :
MMB Messenger
Sun Pharmaceutical Industries Ltd has submitted to BSE a Companys Press Release - announcing about Companys filing on August 27, 2009 of a new application with the U.S. Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice to restart the Hart-Scott- Rodino Act waiting period in connection with the Tender Offer by Alkaloida Chemical Company Exclusive Group Ltd, Companys subsidiary, for all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd.
Further the Company has informed that the Company is filing necessary notification to the U.S. Securities and Exchange Commission informing them about above under required format....
W O N the case
Posted by :
rvk41
The company has won US court ruling in Eli Lilly patent case, that clears way for low-cost cancer drug launch in 2010.
For information,with regards
rvk41...
NSE Announcements on Sun Pharma
Posted by :
MMB MessengerSun Pharmaceuticals Industries Ltd has submitted to the Exchange a copy of the Notice of the Annual General Meeting of the members of the Company to be held on September 11, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
NSE Announcements on Sun Pharma
Posted by :
MMB MessengerSun Pharmaceuticals Industries Ltd has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
$ 2.3 bn ---Annual Sales
Posted by :
rvk41
Sun Pharmaceutical Industries has got the US Food and Drug Administration`s approval to launch its generic version of GlaxoSmithKline`s Imitrex tablets to treat migraine, the Indian drugmaker said.
Sun Pharma, India`s largest drugmaker by market value, has also received US regulatory approval to launch oxaliplatin injections, the copycat version of Sanofi-Aventis` Eloxatin that is used to treat colon and rectal cancer.
Sun Pharma will share a 180-day marketing exclusivity for oxaliplatin with three other generic makers, the Indian firm said.
Oxaliplatin injections have annual sales of about $2.3 billion in the United States.
For information,with regards
rvk41...
BSE Announcements on Sun Pharma
Posted by :
MMB MessengerSun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated August 11, 2009 titled "Sun Pharma announces USFDA approval for generic Eloxatin and Imitrex , Shares 180-day marketing drug exclusivity for generic Eloxatin "...
NSE Announcements on Sun Pharma
Posted by :
MMB MessengerSun Pharmaceuticals Industries Ltd has informed the Exchange regarding a press release dated August 11, 2009, titled "Sun Pharma announces USFDA approval for generic Eloxatin® and Imitrex®". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
Settlement with MedImmune
Posted by :
Poppee55Sun Pharma on high note. We have always maintained that Sun is not for players who are involved in short term gains.We maintain that Sun will touch 1350-1400 before Diwali....
Settlement with MedImmune
Posted by :
123sb
Hi,
This is a good news for this stock and it will move upwards from now onwards and who knows it may also reach its 52 week high in short span of time :) Cheer up and start investing in this stock to get huge benefit.
Thx...



Online



